|
Intranasal Oxytocin Therapy for Obstructive Sleep Apnea
Obstructive sleep apnea (OSA) is a health risk that occurs in 24% of males and 9% of females in the United States. OSA can lead to several cardiovascular diseases including hypertension, arrhythmia, and stroke. Continuous positive airway pressure (CPAP) treatments often fail due to low compliance.
GW Researchers developed an intranasal oxytocin administration...
Published: 1/7/2022
|
Updated: 11/4/2021
|
Inventor(s): David Mendelowitz, Heather Jameson, Vivek Jain, Jay Kimbro
Keywords(s):
Category(s): Technology Classifications > Medical Devices > Cardiology, Technology Classifications > Therapeutics > Proteins and Peptides
|
